Neutrophil-activating therapy for the treatment of cancer is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0.798. It has been cited 204 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.798
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: F30 CA196145
National Institutes of Health
Grant: F31 CA196029
National Institutes of Health
Grant: F32 CA189408
National Institutes of Health
Grant: P01 CA244114
National Institutes of Health
Grant: R01 AI085596
National Institutes of Health
Grant: R01 AI117410
National Institutes of Health
Grant: R01 AI146162
National Institutes of Health
Grant: R01 CA222969
National Institutes of Health
Grant: R01 CA233958
National Institutes of Health
Grant: T32 HL120824
National Institutes of Health
Grant: U54 CA209971
NCI NIH HHS
Grant: R01 CA262361
NCI NIH HHS
Grant: R01 CA251174
Stanford University
FWCI
18.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy
Additional file 1 of Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy